Definitive Competitors

Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Definitive Healthcare's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Definitive Healthcare in the context of predictive analytics.
LowEstimated ValueHigh
LowReal ValueHigh
9 Analysts
LowTarget PriceHigh
Estimates (1)
LowProjected EPSHigh
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Definitive Healthcare. Your research has to be compared to or analyzed against Definitive Healthcare's peers to derive any actionable benefits. When done correctly, Definitive Healthcare's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Definitive Healthcare.

Definitive Healthcare Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Definitive Healthcare and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Definitive and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Definitive Healthcare does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Definitive Healthcare Competition Risk-Adjusted Indicators

Nowadays, there is a big difference between Definitive Stock performing well and Definitive Healthcare company doing well compared to the competition. There are way too many exceptions to the normal that investors can tell for sure what's good or bad unless they analyze Definitive Healthcare's multiple risk-adjusted performance indicators. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
At Risk
SPOK 1.14  0.19  0.08  0.67  1.36  0.08 (1.27)  2.43 (2.32)  8.15 
ADXN 3.15 (0.49)  0.00 (0.75)  0.00 (0.13)  0.00  7.89 (5.56)  18.21 
ALC 1.75  0.01  0.01  0.11  2.05  0.0081 (1.78)  4.49 (3.46)  11.06 
APGN 5.78 (1.64)  0.00 (1.74)  0.00 (0.20)  0.00  7.54 (15.78)  54.29 
ARQT 2.70 (0.70)  0.00 (0.57)  0.00 (0.20)  0.00  4.62 (6.48)  12.73 
ASXC 2.62 (0.46)  0.00 (0.34)  0.00 (0.13)  0.00  4.88 (6.67)  19.06 
ATR 1.36  0.00 (0.01)  0.09  1.58 (0.0065) (1.50)  2.74 (2.53)  6.74 
ATXS 4.30  0.38  0.09  0.44  4.16  0.07 (5.23)  10.23 (6.20)  27.28 
AVTX 3.75  0.36  0.08  0.55  3.61  0.06 (5.15)  11.38 (6.62)  37.28 

Cross Equities Net Income Analysis

Compare Definitive Healthcare and related stocks such as Spok Holdings, Addex Therapeutics, Alcon AG, Apexigen, Arcutis BiotherapeuticsI, Asensus Surgical, AptarGroup, Astria Therapeutics, and Avalo Therapeutics Net Income Over Time
Select Fundamental

SPOK77.9 M88.6 M27 M27.5 M20.7 M84.2 M14 M(15.3 M)(1.5 M)(10.8 M)(44.2 M)(22.2 M)(22.8 M)
ADXN(3.3 M)(3.3 M)(3.3 M)(3.3 M)(3.3 M)(3.3 M)(3.3 M)(3.3 M)(1.6 M)(14.8 M)(12.9 M)(15.4 M)(15.8 M)
ALC308 M308 M308 M308 M308 M308 M(170 M)256 M(227 M)(656 M)(531 M)376 M405.7 M
APGN(24.1 M)(24.1 M)(24.1 M)(24.1 M)(24.1 M)(24.1 M)(24.1 M)(24.1 M)(24.1 M)(24.1 M)(24.1 M)(28.9 M)(31.2 M)
ARQT(5 M)(5 M)(5 M)(5 M)(5 M)(5 M)(5 M)(5 M)(19.3 M)(42 M)(135.7 M)(206.4 M)(211.8 M)
ASXC(5.3 M)(5.8 M)(6.7 M)(28.4 M)(37.7 M)(46.9 M)(120 M)(144.8 M)(61.8 M)(154.2 M)(59.3 M)(62.5 M)(67.4 M)
ATR173.5 M183.7 M162.6 M172 M191.7 M199.3 M205.6 M220 M194.7 M242.2 M214 M244.1 M212.8 M
ATXS(18.1 M)(18.1 M)(18.1 M)(18.1 M)(21.9 M)(32.6 M)(36.1 M)(27.4 M)(25.9 M)(26.3 M)(37.3 M)(194.9 M)(200 M)
AVTX(13 M)(13 M)(13 M)(13 M)(16.1 M)(10.5 M)(16.5 M)11.9 M(40.1 M)(16.1 M)(63.5 M)(84.4 M)(86.6 M)

Definitive Healthcare and related stocks such as Spok Holdings, Addex Therapeutics, Alcon AG, Apexigen, Arcutis BiotherapeuticsI, Asensus Surgical, AptarGroup, Astria Therapeutics, and Avalo Therapeutics Net Income description

Net income is one of the most important fundamental items in finance. It plays a large role in Definitive Healthcare financial statement analysis. It represents the amount of money remaining after all of Definitive Healthcare Corp operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. The portion of profit or loss for the period; net of income taxes; which is attributable to the parent after the deduction of Net Income to Non Controlling Interests from Consolidated Income; and before the deduction of Preferred Dividends.

Definitive Healthcare Competitive Analysis

The better you understand Definitive Healthcare competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Definitive Healthcare's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Definitive Healthcare's competition over several years is one of the best ways to analyze its investment potential.
 Better Than Average     
 Worse Than Peers    View Performance Chart
Spok Holdings
Market Volatility
(90 Days Market Risk)
Market Performance
(90 Days Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Number of Shares Shorted
Shares Owned by Insiders
Current Ratio
Net Asset
Profit Margin
Operating Margin
Current Valuation
Cash Flow from Operations
Retained Earnings
Current Asset
Five Year Return
Price to Book
Shares Outstanding
Annual Yield
Total Debt
Return On Equity
Price to Earning
Z Score
Shares Owned by Institutions
Return On Asset
Book Value Per Share
Cash and Equivalents
Price to Earnings To Growth
Current Liabilities
Total Asset
Short Ratio
Target Price
Last Dividend Paid
Price to Sales
Market Capitalization
Cash per Share
Net Income
Earnings Per Share
Debt to Equity
Working Capital
Gross Profit
Day Typical Price
Accumulation Distribution
Market Facilitation Index
Daily Balance Of Power
Rate Of Daily Change
Day Median Price
Price Action Indicator
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Sortino Ratio
Downside Variance
Standard Deviation
Potential Upside
Treynor Ratio
Maximum Drawdown
Market Risk Adjusted Performance
Risk Adjusted Performance
Semi Deviation
Information Ratio
Value At Risk
Expected Short fall
Downside Deviation
Semi Variance

Definitive Healthcare Competition Performance Charts

Complement your Definitive Healthcare position

In addition to having Definitive Healthcare in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Israel Wall Street Thematic Idea Now

Israel Wall Street
Israel Wall Street Theme
Cross-sector collection of best publicly traded Israel entities that are expected to continue growing. The Israel Wall Street theme has 34 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Israel Wall Street Theme or any other thematic opportunities.
View All  Next Launch
Continue to Definitive Healthcare Correlation with its peers. Note that the Definitive Healthcare information on this page should be used as a complementary analysis to other Definitive Healthcare's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Transaction History module to view history of all your transactions and understand their impact on performance.

Complementary Tools for Definitive Stock analysis

When running Definitive Healthcare price analysis, check to measure Definitive Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Definitive Healthcare is operating at the current time. Most of Definitive Healthcare's value examination focuses on studying past and present price action to predict the probability of Definitive Healthcare's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Definitive Healthcare's price. Additionally, you may evaluate how the addition of Definitive Healthcare to your portfolios can decrease your overall portfolio volatility.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Bond Directory
Find actively traded corporate debentures issued by US companies
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Equity Valuation
Check real value of public entities based on technical and fundamental data
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Is Definitive Healthcare's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Definitive Healthcare. If investors know Definitive will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Definitive Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
1.3 B
Quarterly Revenue Growth YOY
Return On Assets
Return On Equity
The market value of Definitive Healthcare is measured differently than its book value, which is the value of Definitive that is recorded on the company's balance sheet. Investors also form their own opinion of Definitive Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Definitive Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Definitive Healthcare's market value can be influenced by many factors that don't directly affect Definitive Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Definitive Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine Definitive Healthcare value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Definitive Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

USD 12.25  0.20  1.61%   

Definitive Healthcare competes with Spok Holdings, Addex Therapeutics, Alcon AG, Apexigen, and Arcutis BiotherapeuticsI; as well as few others. The company is active under Healthcare sector as part of Health Information Services industry. Analyzing Definitive Healthcare competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Definitive Healthcare to its intrinsic valuation because they are able to contrast its competitors on a relative basis.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Definitive Healthcare competition on your existing holdings. Continue to Definitive Healthcare Correlation with its peers.
Definitive Healthcare Return on Invested Capital is most likely to slightly decrease in the upcoming years. The last year's value of Return on Invested Capital was reported at 0.026. The current Return on Sales is estimated to increase to 0.05, while Return on Average Assets are projected to decrease to (0.008739) . Definitive Healthcare Average Assets are most likely to increase significantly in the upcoming years. The last year's value of Average Assets was reported at 1.93 Billion.